These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 11020235)

  • 41. Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density.
    Chan KW; Duttory A; Yoburn BC
    Eur J Pharmacol; 1997 Jan; 319(2-3):225-8. PubMed ID: 9042594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of kappa opioid receptors in the formalin-induced inhibition of analgesic tolerance to morphine via suppression of conventional protein kinase C activation.
    Fujita-Hamabe W; Nagae R; Nawa A; Harada S; Nakamoto K; Tokuyama S
    J Pharm Pharmacol; 2010 Aug; 62(8):995-1002. PubMed ID: 20663033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of mu-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation.
    Shah S; Duttaroy A; Chen BT; Carroll J; Yoburn BC
    Brain Res Bull; 1997; 42(6):479-84. PubMed ID: 9128924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuation of morphine tolerance after antisense oligonucleotide knock-down of spinal mGluR1.
    Sharif RN; Osborne M; Coderre TJ; Fundytus ME
    Br J Pharmacol; 2002 Jul; 136(6):865-72. PubMed ID: 12110611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system.
    Diaz A; Ruiz F; Flórez J; Hurlé MA; Pazos A
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1545-51. PubMed ID: 7562532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
    Pitts RC; Allen RM; Walker EA; Dykstra LA
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
    Lange DG; Roerig SC; Fujimoto JM; Busse LW
    J Pharmacol Exp Ther; 1983 Jan; 224(1):13-20. PubMed ID: 6681541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine.
    Bagley EE; Chieng BC; Christie MJ; Connor M
    Br J Pharmacol; 2005 Sep; 146(1):68-76. PubMed ID: 15980868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord.
    Nishino K; Su YF; Wong CS; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):67-72. PubMed ID: 2158554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.
    Wang XF; Barbier E; Chiu YT; He Y; Zhan J; Bi GH; Zhang HY; Feng B; Liu-Chen LY; Wang JB; Xi ZX
    J Neurosci; 2016 Oct; 36(40):10392-10403. PubMed ID: 27707973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
    Nowoczyn M; Marie N; Coulbault L; Hervault M; Davis A; Hanouz JL; Allouche S
    Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1991 Nov; 259(2):582-9. PubMed ID: 1658305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.
    DeLander GE; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1984 Oct; 231(1):91-6. PubMed ID: 6092607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the mu-opioid receptor.
    Heinzen EL; Booth RG; Pollack GM
    Biochem Pharmacol; 2005 Feb; 69(4):679-88. PubMed ID: 15670586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic opioid antagonist treatment selectively regulates trafficking and signaling proteins in mouse spinal cord.
    Patel CN; Rajashekara V; Patel K; Purohit V; Yoburn BC
    Synapse; 2003 Oct; 50(1):67-76. PubMed ID: 12872295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tolerance to morphine-like stimulus effects of mu opioid agonists.
    Young AM; Kapitsopoulos G; Makhay MM
    J Pharmacol Exp Ther; 1991 May; 257(2):795-805. PubMed ID: 2033521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCγ signaling pathway.
    Huang YN; Tsai RY; Lin SL; Chien CC; Cherng CH; Wu CT; Yeh CC; Wong CS
    Behav Brain Res; 2012 Apr; 229(2):401-11. PubMed ID: 22309983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO.
    Leventhal L; Stevens LB; Rossi GC; Pasternak GW; Bodnar RJ
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1402-7. PubMed ID: 9316853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
    Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.